Provincial hospital affiliated to shandong University, Jinan, shandong, People's republic of china Purpose: Liver metastasis is one of the leading causes of death in colorectal cancer (CRC) patients. The present study aimed to evaluate the value of eIF4E as a prognostic marker of colo rectal liver metastasis (CLM) and identify the functional role of eIF4E in CRC metastasis.
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Introduction
Colorectal cancer is the fifth most frequently diagnosed cancer and fourth leading cause of cancerrelated mortality in People's Republic of China. 1 According to the data from GLOBOCAN 2012, 253,427 new cases of CRC were diagnosed and 139,416 cases died. 2 With the development of new detection methods and treatment strategies, the 5year survival rate of patients diagnosed with CRC at an early stage has improved to ~80%-90%. 3 However, the survival rate decreased to less than 10% if the patient is diagnosed with distant metastases. 4 Moreover, ~50% of the CRC patients eventu ally develop distant metastasis, 5 and liver is the most common site of metastatic spread. 6 Without treatment, the majority of the CLM patients have a median survival of ~8 months. 7 Thus, assessment of markers predicting CLM and insight into the underlying molecular mechanisms of colorectal metastasis are necessary.
eIF4E is a critical component of the eIF4F trimeric translation initiation complex, it regulates the translation of eukaryotic mRNAs by binding to the 5′ cap. 8 Because submit your manuscript | www.dovepress.com
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Xu et al eIF4E is the least abundant component in the complex, its expression level is believed to be ratelimiting for the translation of capdependent mRNAs. 9 eIF4E is highly expressed in many cancers, 10 and overexpression of eIF4E increases cancer susceptibility by preferentially enhancing the translation of a subset of mRNAs implicated in oncogen esis, such as cell proliferation, invasion, angiogenesis, and metastasis. 11 Previous studies have identified that cyclin D1, VEGF, and MMPs are involved in the development of cancer metastasis. 12, 13 Nevertheless, it remains unknown whether eIF4E regulates the translation of cyclin D1, VEGF, and MMPs in CRC progression and whether eIF4E contributes to CLM.
In the current study, we found the level of eIF4E in CLM tissues was much higher than in nonCLM tissues, and patients with high eIF4E expression had a higher risk of liver metastasis. In addition, eIF4E participated in the prolifera tion, migration, and invasion of CRC cells and regulated the expression of cyclin D1, VEGF, MMP2, and MMP9.
Materials and methods cell lines, tissue specimen, and patients
CRC cell lines were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, People's Republic of China), and cultured as described previously.
14 Forty pairs of CLM tissue, 40 pairs of nonCLM tissue, and patients recruited for the followup assay were obtained from the Department of Gastrointestinal Surgery in Shandong provin cial hospital. There were no significant differences in the age, sex, nutritional status, and accompanying diseases between the groups. None of the patients had received preoperative radiation/chemotherapy. All the patients received standard D2 surgical resection, and the tissues were frozen in liquid nitrogen after removal. The end points of the followup were the occurrence of CLM and cancerrelated death. The study was approved by the Ethical Committee of Shandong Provincial Hospital. Written informed consent was obtained from the participants.
immunohistochemical analysis
Paraffin sections (5 mm) of the tumor tissue were deparaf finized and hydrated, and then incubated overnight at 4°C with eIF4E rabbit monoclonal antibody (#2067, 1:800, Cell Signaling Technology, Inc., Beverly, MA, USA). Secondary staining with biotinconjugated antirabbit IgG, and tertiary staining with horseradish peroxidase (HRP)conjugated streptavidin were performed using an ABC kit (PK6100, Vector, Burlingame, CA, USA). The slides were devel oped with 3,3′diaminobenzidine and counterstained with hematoxylin. Images were captured using a Nikon ECLIPSE TE2000S microscope system (Nikon, Melville, NY, USA).
rT-qPcr
Total RNA was extracted with the TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, UAS), and reverse transcribed using a PrimeScript™ RT reagent kit (Takara, Shiga, Japan). Reverse transcription quantitative polymerase chain reaction (qRTPCR) was performed using a SYBR Premix Ex Taq kit (Takara) on an ABI 7300 (Thermo Fisher Scientific). βactin was amplified as an endogenous control. The relative mRNA expression level was determined using the 2 -ΔΔCt method. 15 The primers used were as follows: eIF4E: forward 5′GAATCTAATCAGGAGGTTGCT3′, reverse 5′CAATCACTATCTTTGGAGGAA3′; β-actin: forward 5′AAAGACCTGTACGCCAACAC3′, reverse 5′GTCATACTCCTGCTTGCTGAT3′. The PCR cycle conditions were 95°C for 30 seconds, followed by 40 cycles at 95°C for 30 seconds, 56°C for 30 seconds, and 72°C for 30 seconds.
Western blot analysis
The harvested cells and tissues were lysed in radioim munoprecipitation assay (RIPA) lysis buffer (Beyotime Institute of Biotechnology, Shanghai, People's Republic of China). The total protein levels were quantified with a BCA Protein Assay kit (Beyotime Institute of Biotechnology). Equal amounts of protein were separated on 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS PAGE), and transferred to polyvinylidene difluoride (PVDF) membranes (EMD Millipore, Billerica, MA, USA). After 1 hour of blocking in 5% nonfat milk, the membranes were washed with Trisbuffered saline with Tween 20 (TBST) and incubated overnight at 4°C with the following primary antibodies: rabbit antieIF4E (#2067, 1:1,000, Cell Signal ing Technology), cyclin D1 (#2922, 1:1,000, Cell Signaling Technology), VEGF (sc152, Santa Cruz Biotechnology Inc., Dallas, TX, USA), rabbit antiMMP2 (#13132, 1:1,000, Cell Signaling Technology), rabbit antiMMP9 (#13667, 1:1,000, Cell Signaling Technology), and mouse antiβactin (sc47778, Santa Cruz Biotechnology Inc.). After wash ing with TBST, the membranes were incubated with goat antirabbit (BA1054, 1:5,000, Wuhan Boster Biological Technology, Ltd., Wuhan, People's Republic of China) and goat antimouse (BA1051, 1:5,000, Wuhan Boster Biological Technology, Ltd.) IgG. The protein signals were detected using an enhanced chemiluminescence (ECL) kit (Pierce, Rockford, IL, USA) with exposure to Xray films (Eastman Kodak, Rochester, NY, USA). 
cell proliferation assay
Cell proliferation was measured using a Cell Counting Kit8 (CCK8, Beyotime Institute of Biotechnology) according to the manufacturer's instructions. Cells were planted into 96well plates at 5×10 3 cells/100 μL/well. After transfection, the optical density was measured at different points (0, 24, 48, and 72 hours) using a microplate reader (iMark; BioRad Laboratories Inc., Hercules, CA, USA).
Migration and invasion assay
Cell migration and invasion abilities were assessed using the Transwell assay. For the invasion assay, the filters (8.0 μm pores, EMD Millipore) were additionally precoated with 30 μL 8× diluted matrix matrigel (BD Biosciences, San Jose, CA, USA) and dried at 37°C. Twenty four hours after transfection, cells were suspended in serumfree medium at a density of 1×10 5 per well and planted into the upper chamber. Complete medium (500 μL) with 10% fetal bovine serum was added to the lower chamber. After 48 hours of incubation at 37°C, the cells that adhered to the lower surface were fixed and stained with 0.1% crystal violet (Beyotime Institute of Biotechnology). The cells were photographed and counted under a microscope.
statistical analysis
Data are presented as the mean ± standard deviation (SD) from at least three independent experiments. Student's ttest was used to compare the results. All statistical analyses were conducted using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). A Pvalue less than 0.05 was considered statistically significant.
Results
The upregulation frequency of eiF4e in the clM group is higher than in the non-clM group A total of 80 pairs of tissue were included, and the cases were divided into the CLM group and nonCLM group (each group had 40 pairs of tissues). The levels of eIF4E in the paired tumor and nontumor tissues were detected by immunohistochemical staining and Western blot. The results of immunohistochemical staining are shown in Figure 1A and B. The eIF4E protein level was higher in tumor tissues than in matched nontumor tissues in both the CLM and nonCLM groups. Western blot indicated the frequency of eIF4E upregulation (ratio of tumor to nontumor tissue $2) was 82.5% (33/40) in the CLM group and 65.0% (26/40) in the nonCLM group (Figure 1C and D) .
Upregulation of eiF4e in crc patients is associated with liver metastasis
To clarify the prognostic value of eIF4E in CLM, we evaluated the level of eIF4E in tumor samples from 80 CRC patients. After surgical resection, the patients were divided into the high eIF4E expression group and low eIF4E expression group (ratio of tumor to nontumor tissue .2) according to Western blot analysis. Fiftyseven patients were included in the high eIF4E expression group, and 23 in the low eIF4E expression group (Figure 2A ). After 2 years of followup, the results indicated the incidence rate of CLM in the high eIF4E expression group was 47.4% (27/57), while it was 13.0% in the low eIF4E expression group (3/23) ( Figure 2B ).
eiF4e is upregulated in crc cell lines
To evaluate the expression level of eIF4E in CRC cells, RT qPCR and Western blot analysis were performed. The five CRC cell lines (LS174T, HT29, Lovo, SW480, and SW620) showed higher eIF4E expression levels than the normal tissue (three pooled normal tissues), and Lovo cells exhibited the highest eIF4E level ( Figure 3A and B).
Downregulation of eiF4e inhibits proliferation, migration, and invasion of crc cells
To explore the possible role of eIF4E in CRC progres sion, eIF4Emediated effects on CRC cell proliferation, migration, and invasion were studied. eIF4E was knocked down using siRNA in Lovo and SW480 cells. Seventy two hours after transfection, RNA and protein were extracted, and qRTPCR and Western blot were performed, respec tively. The expression levels of eIF4E were reduced in both cell lines ( Figure 4A ). The CCK8 assay indicated that knockdown of eIF4E inhibited cell growth compared with control, and the inhibition rate peaked at 72 hours ( Figure 4B ). The wound healing assay showed that down regulation of eIF4E suppressed the migratory activity of Lovo cells. Similar results were obtained in SW480 cells Figure 4C ). In the Transwell assay, cell invasion in two CRC cell lines was decreased following transfection with eIF4E siRNA, when compared to that in control cells ( Figure 4D ).
Knockdown of eiF4e suppresses the expression of cyclin D1, VegF, MMP-2, and MMP-9 in crc cells
To further explore the mechanism of eIF4E in regulating CRC metastasis, the protein levels of VEGF, MMP2, and MMP9 after eIF4E silencing were analyzed. siRNA mediated knockdown of eIF4E decreased the cyclin D1, VEGF, MMP2, and MMP9 protein levels in Lovo ( Figure 5A ) and SW480 cell lines ( Figure 5B ).
Discussion
eIF4E has a critical role in facilitating mRNA translation. Accumulating evidence indicates that eIF4E is associated with cancer development and progression. Overexpression of eIF4E was observed in several cancer types such as breast cancer, 16 gastric cancer, 17 lung cancer, 18 prostate cancer, 19 and leukemia. 20 High eIF4E expression level in breast cancer was associated with a greater rate of cancer recurrence and worse survival. 16, 21 Overexpression of eIF4E is associated with 
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Xu et al β vascular invasion in gastric cancer, 17 and it may serve as a prognostic and therapeutic factor for lung cancer, melanoma, and chronic lymphocytic leukemia (CLL) lymphocytes. 20, 22, 23 In colorectal cancer, the eIF4E expression level increased steadily as the cancer progressed from benign dysplasia to adenocarcinoma. 24 Therefore, eIF4E was selected for further research.
In the present study, the level of eIF4E in CRC tissues was evaluated, and the protein level of eIF4E was increased in the CLM and nonCLM tissues compared with matched nontumor tissues. This result is consistent with previous reports. 24, 25 The upregulation rate of eIF4E in the CLM group (82.5%) was much higher than that in the nonCLM group (65.0%), indicating that elevated eIF4E expression is OncoTargets and Therapy 2016:9 submit your manuscript | www.dovepress.com
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eiF4e is associated with liver metastasis associated with higher liver metastasis in CRC patients. We further confirmed the result by following 80 CRC patients after they underwent surgical resection. After 2 years, 27 patients in the high eIF4E expression group had liver metas tasis, and only three patients in the low eIF4E expression group had liver metastasis; these results suggest that patients with high eIF4E expression level had a higher risk of liver metastasis. These data indicated eIF4E expression level is associated with liver metastasis in the CRC patients.
Further studies of eIF4E in CRC cells were performed. The eIF4E level was elevated in CRC cells compared to the normal tissue, and highly metastatic Lovo and SW620 cells have higher eIF4E levels than low metastatic LS174T, HT29, and SW480 cells. We then investigated the effect of eIF4E on CRC metastasis by performing lossoffunction assays. Knockdown of eIF4E suppressed the proliferation, migration, and invasion of Lovo and SW480 cells. A major obstacle to CRC treatment is tumor metastasis, and the func tional studies indicated that eIF4E is associated with tumor cell migration and invasion. As a result, we further explored the underlying mechanism.
Cyclin D1, VEGF, MMP2, and MMP9 are vital mole cules involved in tumor metastasis. 13 Cyclin D1 is required for cell growth and cell cycle control, and it is frequently overexpressed in human tumors. 26 A previous study demon strated that cyclin D1 was downregulated in eIF4Esilenced HeLa cells. 27 The results of the present study showed that the expression of cyclin D1 was reduced after eIF4E knock down in the two CRC cell lines. VEGF is a key mediator of tumor angiogenesis in the development of metastases.
28
MMP2 and MMP9 are the MMPs that contribute to tumor invasion and metastasis by degrading collagen IV and other extracellular matrix proteins. The data indicated that with the downregulation of eIF4E, the expression levels of VEGF, MMP2, and MMP9 were reduced to a different extent. These results suggest that downregulation of eIF4E inhibits CRC cell metastasis partly through regulating the expression of cyclin D1, VEGF, MMP2, and MMP9.
Conclusion
In summary, the present study demonstrated that patients with high eIF4E expression levels had more frequent liver metastasis, suggesting the prognostic effect of eIF4E on CLM. Downregulation of eIF4E suppressed tumor metasta sis, in part, through regulating the expression of cyclin D1, VEGF, MMP2, and MMP9. 
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